New Treatments for Liver Disease tagged posts

Investigators have developed a ‘lab on a chip’ technology that can simulate different levels of Non-alcoholic Fatty Liver Disease progression. Non-alcoholic fatty liver disease (NAFLD) – the accumulation of liver fat in people who drink little or no alcohol – is increasingly common around the world, and in the United States, it affects between 30 and 40 percent of adults. Currently, there are no approved drugs for the treatment of NAFLD, which is predicted to soon become the main cause of chronic liver problems and the need for liver transplantation.

Now a team led by investigators at Massachusetts General Hospital (MGH) has developed a “lab on a chip” technology that can simulate different levels of NAFLD progression in cells across a sing...